Sami A. Nachman
Michael Miksa
Pediatric critical care
<p>Physician-Scientist, Michael Miksa, MD, PhD received his medical degree from the Free University of Berlin in Germany and his academic degree magna cum laude from The Charité – Universitätsmedizin Berlin. He completed his pediatric residency training at State University of New York (SUNY) Downstate, a critical care fellowship at Yale and had worked in the pediatric emergency department for the Boston Children’s Hospital.</p><p>Dr. Miksa presented his work at several meetings both nationally and abroad and is Site Investigator for NEAR4KIDS, a multi-center quality improvement study to limit adverse events during intubations.</p>
Courtney A. McNamara
<p>Courtney McNamara, MD, is Associate Program Director, Pediatric Residency Program at the Children’s Hospital at Montefiore Einstein (CHAM) and Assistant Professor, Pediatrics at our Albert Einstein College of Medicine. Her clinical focus is on pediatric hospital medicine, with a particular interest in resident education and mentorship.</p><p>In 2006, Dr. McNamara received her Bachelor of Science at James Madison University. She pursued her medical education at New York Medical College, earning her Doctor of Medicine in 2010. She then came to CHAM for her postgraduate training, completing her pediatric residency in 2013.</p><p>Dr. McNamara’s research focuses on improving the patient experience. She is a co-investigator in a grant funded project investigating communication with hospitalized patients with limited English proficiency, and her body of research includes quality improvement research studies focused on improving inpatient pediatric comfort and decreasing painful experiences. She has shared her work through peer-reviewed journals, abstracts, poster presentations and platform presentations.</p><p>Dr. McNamara is board certified in both General Pediatrics and Pediatric Hospital Medicine by the American Board of Pediatrics. She is a member of the American Academy of Pediatrics. In 2023, Dr. McNamara was inducted into the Leo M. Davidoff Society.</p>
Ali Y. Mansour
C<span style="color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">linical focus includes interventional pulmonary medicine, interstitial lung disease, lung transplantation, vascular medicine and sleep medicine.</span><quillbot-extension-portal></quillbot-extension-portal>
<span style="color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Dr. Mansour’s research focuses on lung transplant and extracorporeal membrane oxygenation (ECMO) support during critical illnesses from severe lung disease.</span><quillbot-extension-portal></quillbot-extension-portal>
<p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Ali Mansour, MD, is Medical Director, Advanced Pulmonary Failure and Lung Transplantation and Assistant Professor at Montefiore Einstein. His clinical focus includes interventional pulmonary medicine, interstitial lung disease, lung transplantation, vascular medicine and sleep medicine.</p><p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">In 2000, Dr. Mansour received his Bachelor of Chemistry at the American University of Beirut. He continued his studies at this institution and received his Doctor of Medicine in 2004. Dr. Mansour began his postgraduate training in 2004 with a yearlong internship at the American University of Beirut Medical College. His training then took him to Kansas, where he completed an internship and residency in internal medicine in 2008 at the Kansas University Medical School. Following this, Dr. Mansour completed a fellowship in pulmonary and critical care that included advanced fellowship training in pulmonary transplantation at Baylor College of Medicine in 2011. In 2012, he completed a sleep fellowship at the University Hospital Case Western Medical Center. Dr. Mansour is board certified in echocardiography and vascular medicine and is accredited as an interventional pulmonologist.</p><p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Dr. Mansour’s research focuses on lung transplant and extracorporeal membrane oxygenation (ECMO) support during critical illnesses from severe lung disease. He is also interested in lung cancer staging and advanced airway procedure to improve and prolong survival. More recently, he supervises numerous clinical studies and trials including novel therapies for SARS-CoV-2. His work has been published in a number of peer-reviewed publications, and he has been an invited speaker to numerous national oral presentations.</p><p style="padding-top:0px;color:#525458;font-family:Arial, Helvetica, sans-serif;background-color:#ffffff;">Dr. Mansour is a member of numerous professional societies, including the American Thoracic Society, the American Academy of Sleep Medicine and the American Association for Bronchology and Interventional Pulmonology. He is a fellow of the American College of Chest Physicians.</p>
Rishi Malhotra
<span style="caret-color:#000000;font-family:Calibri, Arial, Helvetica, sans-serif;font-size:16px;text-size-adjust:auto;background-color:#ffffff;">Subarachnoid hemorrhage, Intracerebral Hemorrhage, Ischemic Stroke, Status Epilepticus, Neuromuscular Respiratory Failure, CNS Infections</span>
<span style="caret-color:#000000;font-family:Calibri, Arial, Helvetica, sans-serif;font-size:16px;text-size-adjust:auto;background-color:#ffffff;">Intracerebral Hemorrhage</span>
<p>Rishi Malhotra, MD, is Director of Neurocritical Care, Director of the Neuroscience ICU and Director of the Neurocritical Care Fellowship, as well as Associate Professor of Neurology, Medicine and Neurological Surgery at Montefiore Einstein. Dr. Malhotra’s clinical focus includes the critical care management of subarachnoid hemorrhage, intracerebral hemorrhage, traumatic brain injury, acute spinal cord injury, ischemic stroke, status epilepticus, brain tumors, neuromuscular respiratory failure and central nervous system infections.</p><p>A graduate of the combined BA/MD program at Brooklyn College, Dr. Malhotra completed his Doctor of Medicine with State University of New York - Downstate Medical Center in 2004. After completing his internal medicine internship at St. Luke’s-Roosevelt Hospital in 2005, Dr. Malhotra completed his three-year neurology residency at Columbia University Medical Center in 2008. He then pursued a neurocritical care fellowship at Columbia University Medical Center and Weill Cornell Medical Center, which he completed in 2010.</p><p>Dr. Malhotra’s scholarly interests include intracerebral hemorrhage, hypoxic-ischemic brain injury and status epilepticus. He has shared his work through peer-reviewed journals, books, abstracts and poster presentations.</p><p>Dr. Malhotra is board certified in Neurology and Neurocritical Care. He is a member of the Neurocritical Care Society.</p>
Andrea S. Kermack
Mahsa Kanzali
Tannaz Iranpour Boroujeni
Michelle Ng Gong
<p>Dr. Gong is the Chief of Critical Care Medicine, Chief of Pulmonary Medicine, and Director of Critical Care Research at Montefiore Medical Center and Professor in Medicine and in Epidemiology and Population Health at Albert Einstein College of Medicine. After receiving an engineering degree at the University of Pennsylvania, Dr. Gong went on to earn a medical degree at the Yale University School of Medicine. She then completed her postdoctoral training at the Beth Israel Hospital in medicine and at the Brigham and Women’s Hospital in the Harvard Combined Program in Pulmonary and Critical Care Medicine. She also studied at the Harvard School of Public Health, receiving her Master’s degree in Clinical Epidemiology. Prior to coming to Albert Einstein College of Medicine and Montefiore Medical Center, she was Assistant Professor of Medicine in the division of Pulmonary, Critical Care and Sleep Medicine at the Mount Sinai School of Medicine. She joined the Einstein/Montefiore faculty in July 2009.</p>
<p>Dr. Gong is recognized nationally and internationally for her expertise in critical care delivery and management of acute respiratory failure and acute respiratory distress syndrome (ARDS). She has spent her career on improving outcomes in patients along the entire continuum of critical illness from its development to its progression and recovery with an overall focus on the prediction and prevention of acute organ failure and their complications. Nationally, she is a well-respected clinical researcher and trialist in acute injury and critical illness. Continuously funded by the NIH for over 20 years for her work, her research ranges from COVID-19 and ARDS to prevention of delirium, treatment of severe influenza, big data and predictive analytics in risk prediction, and effective clinical decision support systems. Her research has been published in the New England Journal of Medicine and JAMA. She has also been funded by the AHRQ on clinical decision making in ARDS and by the NHLBI for the Montefiore-Sinai Clinical Center for the PETAL Clinical Trials Network focused on the prevention and early treatment of ARDS.</p>
<p>A model clinician-researcher, her scientific projects influence her clinical care, and her patients motivates her research. So it is not surprising that some of her proudest achievements have occurred within her clinical work to improve outcomes for patients within Montefiore. This has included process improvement projects such as the implementation of sedation and delirium protocols and early mobilization in the medical intensive care unit that has reduced duration of mechanical ventilation, length of stay, hospital costs and ICU complications. She has also worked on the incorporation of artificial intelligence to help identify patients at increased risk of poor outcomes at Montefiore and evaluation of clinical decision support systems. She has co-authored the Surviving Sepsis Guidelines on management of patients with COVID-19, published in Intensive Care Medicine. </p>
<p>Dr. Gong is a well-regarded leader in the field of pulmonary and critical care medicine. She is a graduate of the prestigious Executive Leadership in Academic Medicine Fellowship and was the former or current chair of the Critical Care Planning Committee and the Critical Care Assembly for the American Thoracic Society. She is also on the Discovery Oversight Committee that helps plan the direction and agenda for the clinical trials initiative of the Society of Critical Care Medicine. Dr. Gong was awarded the Gotham Icon Award for Champions and Change Makers of New York City by the Museum of the City of New York in 2020. Given her expertise, she has been named to multiple panels to develop clinical practice guidelines, including the American College of Chest Physicians and the American Thoracic Society clinical practice guidelines for liberation from mechanical ventilation and the Surviving Sepsis Campaign guidelines for management of severe COVID-19 in 2020. In these leadership positions, she has had the fortune and privilege to mentor residents, fellows and junior investigators both within and beyond Montefiore into productive, academic careers in medicine.</p>
Dr. Gong’s clinical focus is on critical care delivery, predictive analytics, and process improvements, such as the implementation of sedation and delirium protocols and early mobilization in the medical intensive care unit, which has reduced the duration of mechanical ventilation, length of stay, hospital costs, and ICU complications.
Current research ranges from acute respiratory distress syndrome to prevention of delirium, treatment of severe influenza, big data and predictive analysis in risk prediction, and effective clinical decision support systems.
<p>Michelle N. Gong, MD, MS, is a Professor of Medicine and Epidemiology and Population Health at Albert Einstein College of Medicine. She is also the Chief of Critical Care Medicine, Associate Chief of Academic Affairs, and Director of Critical Care Research at Montefiore. Dr. Gong’s clinical focus is on critical care delivery, predictive analytics, and process improvements, such as the implementation of sedation and delirium protocols and early mobilization in the medical intensive care unit, which has reduced the duration of mechanical ventilation, length of stay, hospital costs, and ICU complications. She joined the Einstein/Montefiore faculty in July 2009.</p> <p>Dr. Gong received an Engineering degree at the University of Pennsylvania. She then went on to earn her Doctor of Medicine at the Yale University School of Medicine. She completed her postdoctoral training at the Beth Israel Hospital in medicine and at the Brigham and Women’s Hospital in the Harvard Combined Program in Pulmonary and Critical Care Medicine. Dr. Gong studied at the Harvard School of Public Health, receiving her Master’s Degree in Clinical Epidemiology. </p>Dr. Gong has spent her career improving outcomes in patients along the entire continuum of critical illness, from its development to progression and recovery, with an overall focus on the prediction and prevention of acute organ failure and its complications. Her current research ranges from acute respiratory distress syndrome to prevention of delirium, treatment of severe influenza, big data and predictive analysis in risk prediction, and effective clinical decision support systems. Under her leadership, Montefiore/Einstein was selected as a clinical center for the NHLBI Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network which represents the first representation of a medical center from the New York and the tri-state area. Collaborating with the research informatics and healthcare industries, Dr. Gong has fostered the application of informatic approaches to drive improvement in healthcare delivery and research.</p><p>In 2013, Dr. Gong received the ATS Innovation in Fellowship Education Award. She is board certified by the American Board of Internal Medicine in Internal Medicine, Critical Care Medicine, Palliative Care Medicine, and Pulmonary Medicine. </p>